VERABREICHUNG EINES ANTITUMORMITTELS

Patent europeic · EP2827858 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2827858
Numer da la dumonda
EP13711004
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
15-03-2013
Publitgà
28-01-2015
Concedì
20-07-2016
La protecziun finescha il pli tard
14-03-2033
Proxima taxa annuala scadenta
31-03-2027
Classas IPC
A61K 9/14 (2006.01)
A61K 31/40 (2006.01)
A61P 35/00 (2006.01)
Prioritad
US 201261612429 P 19.03.2012
Dumonda PCT
PCT/EP2013/055324 15.03.2013
Publicaziun PCT
WO2013/139687 26.09.2013
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-04-2026

    Midada

    Published in Swissreg on 01.04.2026

  2. 01-04-2025

    Midada

    Published in Swissreg on 01.04.2025

  3. 01-04-2024

    Midada

    Published in Swissreg on 01.04.2024

  4. 01-04-2023

    Midada

    Published in Swissreg on 01.04.2023

  5. 20-07-2016

    Concedì

    Published in Swissreg on 20.07.2016

Partidas

Possessur

F. Hoffmann-La Roche AG

F.Hoffmann-La Roche AG

Grenzacherstrasse 124, 4070 Basel

Inventur

GLENN, Kelli

Roseland New Jersey 07068, US

HIGGINS, Brian

Fresh Meadows New York 11365, US

NICHOLS, Gwen

New York New York 10128, US

PACKMAN, Kathryn E.

Bloomfield New Jersey 07003, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.